Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Winchester, VA Accepting Medicare

4 Thoracic Surgery (Cardiothoracic Vascular Surgery) doctors found. Showing 1 - 4

Shalini Rohini Reddy, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 400 Campus Blvd Ste 210, Winchester, VA 22601 Phone: 540-536-3470    Fax: 540-536-3471

Dr. Percival Ofrecio Buenaventura, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst St Ste 310, Winchester, VA 22601 Phone: 540-536-6721    Fax: 540-536-6724

Dr. Edward R Kofsky, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst St Ste 310, Winchester, VA 22601 Phone: 540-536-6721    Fax: 540-536-6724

Ernesto Jimenez, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1880 Amherst St Ste 310, Winchester, VA 22601 Phone: 540-536-6721    Fax: 540-536-6724

News Archive

New study reveals the importance of bowel preparation prior to procedure

While there is little doubt concerning the effectiveness of colonoscopy procedures to detect colon cancer, a new study presented at the American College of Gastroenterology's 74th Annual Scientific Meeting in San Diego places new emphasis on the importance of adequate bowel preparation prior to procedure.

Women more likely to be hospitalised after asthma emergency care

US research shows that women who attend the emergency department with acute asthma are almost twice as likely to be admitted to hospital than men despite several measures of asthma control, treatment and severity being more favourable in women.

Positive results from Incyte's COMFORT-I INCB18424 pivotal Phase III clinical trial in myelofibrosis

Incyte Corporation announced today positive top-line results from COMFORT-I, the pivotal Phase III clinical trial of INCB18424 (also known as INC424) in patients with myelofibrosis (MF) being conducted under a Food and Drug Administration (FDA) Special Protocol Assessment (SPA) Agreement. COMFORT-I (COntrolled MyeloFibrosis Study with ORal JAK Inhibitor Treatment) is a double-blind, placebo-controlled Phase III trial involving 309 patients.

NTDs have 'devastating consequences' for 1 out of 6 people worldwide

"There are so many things we take for granted in America. One of them is that our children are not regularly infected by one of the tropical diseases so common among the world's poorest people," Richard Besser, ABC News' chief health and medical editor, writes in an ABC News opinion piece.

DFG now extends funding for research on immunological therapy at Charité

The DFG (Deutsche Forschungsgemeinschaft) has now extended the funding of a research association which is located at the Charité - Universitätsmedizin Berlin. The Collaborative Research Centre (SFB) will receive funding in excess of ten million Euros over the next four years.

Read more Medical News

› Verified 9 days ago